{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:40:14Z","timestamp":1773031214434,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lifetech Scientific"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.carrev.2020.09.031","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T12:44:51Z","timestamp":1600951491000},"page":"72-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Post-Market Clinical Follow-Up With the Patent Foramen Ovale Closure Device IrisFIT (Lifetech) in Patients With Stroke, Transient Ischemic Attack, or Other Thromboembolic Events"],"prefix":"10.1016","volume":"30","author":[{"given":"Kolja","family":"Sievert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Bertog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph Stephan","family":"von Bardeleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Gafoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Predrag","family":"Matic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalan","family":"Schnelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.09.031_bb0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.107.709972","article-title":"Overview of the 2007 food and drug administration circulatory system devices panel meeting on patent foramen ovale closure devices","volume":"116","author":"Slottow","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.09.031_bb0010","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/01.STR.24.12.1865","article-title":"Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography","volume":"24","author":"Cabanes","year":"1993","journal-title":"Stroke."},{"key":"10.1016\/j.carrev.2020.09.031_bb0015","first-page":"446","article-title":"Patent foramen ovale and cerebrovascular diseases","volume":"3","author":"Desai","year":"2006","journal-title":"Nature Clinical Practice"},{"key":"10.1016\/j.carrev.2020.09.031_bb0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacc.2006.08.063","article-title":"Patent foramen ovale and the risk of ischemic stroke in a multiethnic population","volume":"49","author":"Di Tullio","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2020.09.031_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CRD.0b013e31815771e4","article-title":"PFO and stroke: what are the data?","volume":"16","author":"Wechsler","year":"2008","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.carrev.2020.09.031_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00392-011-0392-2","article-title":"Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years","volume":"101","author":"Fischer","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.carrev.2020.09.031_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10072-007-0763-7","article-title":"The patent foramen ovale \u2013 migraine question","volume":"28","author":"Tepper","year":"2007","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.carrev.2020.09.031_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0735-1097(85)80103-0","article-title":"Severe hypoxemia due to shunting through a patent foramen ovale: a correctable complication of right ventricular infarction","volume":"5","author":"Bansal","year":"1985","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2020.09.031_bb0045","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ehj.2004.04.028","article-title":"Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale","volume":"25","author":"Torti","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.carrev.2020.09.031_bb0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Massardier E et al for the CLOSE investigators. CLOSE trial: patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2020.09.031_bb0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"REDUCE trial: patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2020.09.031_bb0060","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"RESPECT trial: closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"377","author":"Carrol","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2020.09.031_bb0065","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2018.03.460","article-title":"DEFENSE PFO trial: cryptogenic stroke and high-risk patent foramen ovale","volume":"71","author":"Lee","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2020.09.031_bb0070","first-page":"182","article-title":"The Occlutech Figulla PFO and ASD Occluder: a new nitinol wire mesh device for closure of atrial septal defects","volume":"22","author":"Krizanic","year":"2010","journal-title":"J. Invasive Cardiol."}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920305819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920305819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:21:25Z","timestamp":1761560485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920305819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":14,"alternative-id":["S1553838920305819"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.09.031","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Market Clinical Follow-Up With the Patent Foramen Ovale Closure Device IrisFIT (Lifetech) in Patients With Stroke, Transient Ischemic Attack, or Other Thromboembolic Events","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}